Jill JF Belch

Has grant

Academic, Clinical Professor (Teaching and Research) of Vascular Medicine

University of Dundee
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jill JF Belch is a Clinical Professor of Vascular Medicine at the University of Dundee, United Kingdom. Her research primarily focuses on venous thromboembolism, wet macular degeneration, and sex-specific cardiovascular outcomes. Notable recent publications include the 2025 ESVM guidelines on interventional treatment of venous thromboembolism and editorials addressing exercise therapy for chronic symptomatic peripheral artery disease. Dr. Belch is also actively involved in exploring the implications of sex in cardiac operations and the ASSIGN score's relationship with cancer risk.

Recent Grants

Grant: Close

Promoting the detection of vascular risk: SHARP

Open Date: 2020-01-01

Close Date: 2025-01-01

Grant: Close

Cardiovascular Research: From Imaging to Population Health, TICR

Open Date: 2019-01-01

Close Date: 2022-01-01

Grant: Close

SHHEC Research Coalition: a study of novel markers for chronic disease, data linkage with EDRIS

Open Date: 2019-01-01

Close Date: 2022-01-01

Grant: Close

Pollution and Air Quality Management Area (AQMA)

Open Date: 2019-01-01

Close Date: 2021-01-01

Grant: Close

SHHEC Research Coalition: a study of novel markers for cardiovascular disease, Alzheimer’s and cancer, data linkage with EDRIS

Open Date: 2018-01-01

Close Date: 2021-01-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Summary: Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions. It should help the health professionals in all fields of vascular medicine to make decisions in daily practice for safe use of contrast media.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

Marco De Carlo

University of Pisa

ITALY
View details

Anna Falanga

Full Professor of Hematology

University of Milano-Bicocca

ITALY
View details

Juraj Madaric

-

SLOVAKIA
View details

Victor Aboyans

-

FRANCE
View details

Faisel Khan

Academic, Professor (Teaching and Research) of Cardiovascular Sciences

University of Dundee

UNITED KINGDOM
View details

Sam Schulman

Professor

McMaster University

CANADA
View details

Christian Heiss

Professor of Cardiovascular Medicine, Head of Department

University of Surrey

UNITED KINGDOM
View details

Daniel Staub

Head of Department

University Hospital Basel

SWITZERLAND
View details

Stefano Lanzi

Lausanne University Hospital

SWITZERLAND
View details

Nasser Malyar

University Hospital

GERMANY
View details

Angela Shore

Professor of Cardiovascular Science

University of Exeter

UNITED KINGDOM
View details

Konstantinos Kyriakoulis

-

GREECE
View details

Peter Marschang

Medical University of Innsbruck

AUSTRIA
View details

Chris Seenan

Senior Lecturer

Glasgow Caledonian University

UNITED KINGDOM
View details

Maarit Venermo

University of Helsinki

FINLAND
View details

Francesco Casanova

University of Exeter Medical School

UNITED KINGDOM
View details

MARIA CATALANO

University of Milan

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.